Impact of resource availability on outcomes of diffuse large B-cell lymphoma: real-world data from Pakistan

• Patients treated in low- and middle-income countries have restricted access to detailed immunohistochemistry, FISH testing, PET scan, and rituximab. • Patients treated in resource-limited settings have inferior OS and DFS, compared to resource-enhanced settings. The purpose of this study is to assess the impact of resource availability on the outcomes of diffuse large B-cell lymphoma (DLBCL) and identify areas of improvement in managing DLBCL in resource-limited settings. This multicentric retrospective study included 756 patients across 12 public and private hematology, oncology, and hematopoietic stem cell transplant centers in Pakistan. The median age at diagnosis was 47.92 years (range, 14-89), which was higher in resource-enhanced settings than resource-limited ones ( P =.001). The male-to-female ratio was 2:1. Detailed immunohistochemistry was available for 22 patients (4.3%) in resource-limited vs 155 (59.3%) resource-enhanced settings ( P = .000). Higher International Prognostic Index scores, advanced stage, and central nervous system disease were seen in resource-limited settings ( P = .000). Computed tomography scan was the primary diagnostic modality in resource-poor settings, compared to positron emission tomography scan (64% vs 38.8%; P = .000). Complete response (CR) rate was lower for resource-limited settings (35.5% vs 54.4%; P = .000). R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) yielded a higher CR than CHOP ( P = .000). Only 10 relapsed/refractory patients (29%) in resource-limited setting received salvage treatment compared to 15 (48%) in resource-enhanced setting ( P = .02). For the entire cohort, overall survival was 40.6%, higher in resource-enhanced setting (53% vs 35.2%; P = .000). Disease-free survival was 36.3% (47% in resource-enhanced vs 31.4% in resource-limited settings; P = .000). The study highlights disparity in outcomes between patients in resource-limited vs resource-enhanced settings. Efforts are required to bridge this gap by uniform resource allocation and establishing specialized centers.

Authors

Institutions

Publication Details

Journal
Blood Global Hematology
Published
2025-04-23
DOI
https://doi.org/10.1016/j.bglo.2025.100010
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of resource availability on outcomes of diffuse large B-cell lymphoma: real-world data from Pakistan

Nida Anwar, Munira Moosajee, Amina Risalat, Zeba Aziz et al.
Blood Global Hematology
Chronic Lymphocytic Leukemia Research
article

Impact of resource availability on outcomes of diffuse large B-cell lymphoma: real-world data from Pakistan

Nida Anwar, Munira Moosajee, Amina Risalat, Zeba Aziz, Nargis Aalam Abro, Zeeshan Ahmed Khan, Misbah Masood, Humera Mahmood, Raheel Iftikhar, Usman Ahmad
article en

Abstract

• Patients treated in low- and middle-income countries have restricted access to detailed immunohistochemistry, FISH testing, PET scan, and rituximab. • Patients treated in resource-limited settings have inferior OS and DFS, compared to resource-enhanced settings. The purpose of this study is to assess the impact of resource availability on the outcomes of diffuse large B-cell lymphoma (DLBCL) and identify areas of improvement in managing DLBCL in resource-limited settings. This multicentric retrospective study included 756 patients across 12 public and private hematology, oncology, and hematopoietic stem cell transplant centers in Pakistan. The median age at diagnosis was 47.92 years (range, 14-89), which was higher in resource-enhanced settings than resource-limited ones ( P =.001). The male-to-female ratio was 2:1. Detailed immunohistochemistry was available for 22 patients (4.3%) in resource-limited vs 155 (59.3%) resource-enhanced settings ( P = .000). Higher International Prognostic Index scores, advanced stage, and central nervous system disease were seen in resource-limited settings ( P = .000). Computed tomography scan was the primary diagnostic modality in resource-poor settings, compared to positron emission tomography scan (64% vs 38.8%; P = .000). Complete response (CR) rate was lower for resource-limited settings (35.5% vs 54.4%; P = .000). R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) yielded a higher CR than CHOP ( P = .000). Only 10 relapsed/refractory patients (29%) in resource-limited setting received salvage treatment compared to 15 (48%) in resource-enhanced setting ( P = .02). For the entire cohort, overall survival was 40.6%, higher in resource-enhanced setting (53% vs 35.2%; P = .000). Disease-free survival was 36.3% (47% in resource-enhanced vs 31.4% in resource-limited settings; P = .000). The study highlights disparity in outcomes between patients in resource-limited vs resource-enhanced settings. Efforts are required to bridge this gap by uniform resource allocation and establishing specialized centers.

Blood Global HematologyVol. 1(1)
Jinnah Postgraduate Medical Center (PK), Punjab Institute of Cardiology (PK), Armed Forces Institute of Pathology (PK), Rashid Latif Medical College (PK), Latifa Hospital (AE), Aga Khan University Hospital (PK), Karachi Institute of Radiotherapy and Nuclear Medicine (PK), Shaukat Khanum Memorial Cancer Hospital and Research Center (PK), National Institute Of Blood Disease and Bone Marrow Transplantation (PK)
Openalex Percentile: Top 88%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.